Advertisement

Comprehensive heart failure assessment: A challenge to modify the course of heart failure

Published:December 05, 2019DOI:https://doi.org/10.1016/j.ejim.2019.11.013
      Heart failure (HF) is a syndrome linked to ageing that entails poor health outcomes [
      • Martín-Sánchez F.J.
      • Marino-Genicio R.
      • Rodríguez-Adrada E.
      • Jacob J.
      • Herrero P.
      • Miró O.
      • et al.
      Management of acute heart failure in spanish emergency departments based on age.
      ]. HF patients usually present a high number of comorbidities [
      • Martín-Sánchez F.J.
      • Marino-Genicio R.
      • Rodríguez-Adrada E.
      • Jacob J.
      • Herrero P.
      • Miró O.
      • et al.
      Management of acute heart failure in spanish emergency departments based on age.
      ]. Grade of comorbidity is increased with age and is associated with worsening of symptoms, hospital admissions, and mortality among HF subjects [
      • Ahluwalia S.C.
      • Gross C.P.
      • Chaudhry S.I.
      • Ning Y.M.
      • Leo-Summers L.
      • Van Ness P.H.
      • et al.
      Impact of comorbidity on mortality among older persons with advanced heart failure.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Martín-Sánchez F.J.
        • Marino-Genicio R.
        • Rodríguez-Adrada E.
        • Jacob J.
        • Herrero P.
        • Miró O.
        • et al.
        Management of acute heart failure in spanish emergency departments based on age.
        Rev Esp Cardiol (Engl Ed). 2013; 66: 715-720
        • Ahluwalia S.C.
        • Gross C.P.
        • Chaudhry S.I.
        • Ning Y.M.
        • Leo-Summers L.
        • Van Ness P.H.
        • et al.
        Impact of comorbidity on mortality among older persons with advanced heart failure.
        J Gen Intern Med. 2012; 27: 513-519
      1. Correale M., Paolillo S., Mercurio V., Limongelli G., Barillà F., Ruocco G., et al. Comorbidities in Acute and Chronic Heart Failure: a position paper from Italian Society of Cardiology (SIC) Working Group on Heart Failure. 2019. doi: https://doi.org/10.1016/j.ejim.2019.10.008.

        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey Jr, D.E.
        • Colvin M.M.
        • et al.
        ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart failure society of America.
        Circulation. 2017; 136 (2017): e137-e161
        • Ponikowski P.
        • Voors A.A.
        • Anker S.D.
        • Bueno H.
        • Cleland J.G.F.
        • Coats A.J.S.
        • et al.
        ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
        Eur Heart J. 2016; 37 (2016): 2129-2200
        • Wong C.Y.
        • Chaudhry S.I.
        • Desai M.M.
        • Krumholz H.M.
        Trends in comorbidity, disability, and polypharmacy in heart failure.
        Am J Med. 2011; 124: 136-143
        • Rankin A.
        • Cadogan C.A.
        • Patterson S.M.
        • Kerse N.
        • Cardwell C.R.
        • Bradley M.C.
        • et al.
        Interventions to improve the appropriate use of polypharmacy for older people.
        Cochrane Database Syst Rev. 2018; 9 (CD008165)
        • Martín-Sánchez F.J.
        • Christ M.
        • Miró Ò.
        • Peacock W.F.
        • McMurray J.J.
        • Bueno H.
        • et al.
        Practical approach on frail older patients attended for acute heart failure.
        Int J Cardiol. 2016; 222: 62-71
        • Wang X.
        • Zhou C.
        • Li Y.
        • Li H.
        • Cao Q.
        • Li F.
        Prognostic value of frailty for older patients with heart failure: a systematic review and meta-analysis of prospective studies.
        Biomed Res Int. 2018; 20188739058
        • Llopis García G.
        • Munck Sánchez S.
        • García Briñón M.A.
        • Fernández Alonso C.
        • González del Castillo J.
        Martín-Sánchez FJ physical frailty and its impact on long-term outcomes in older patients with acute heart failure after discharge from an emergency department.
        Emergencias. 2019; 31: 413-416
        • Ellis G.
        • Gardner M.
        • Tsiachristas A.
        • Langhorne P.
        • Burke O.
        • Harwood R.H.
        • et al.
        Comprehensive geriatric assessment for older adults admitted to hospital.
        Cochrane Database Syst Rev. 2017; 9 (CD006211)
        • Martín-Sánchez F.J.
        • Rodríguez-Adrada E.
        • Vidán M.T.
        • Díez Villanueva P.
        • Llopis García G.
        • González Del Castillo J.
        • et al.
        Impact of geriatric assessment variables on 30-day mortality among older patients with acute heart failure.
        Emergencias. 2018; 30: 149-155
        • Rodriguez-Pascual C.
        • Paredes-Galan E.
        • Vilches-Moraga A.
        • Ferrero-Martinez A.I.
        • Torrente-Carballido M.
        • Rodriguez-Artalejo F.
        Comprehensive geriatric assessment and 2-year mortality in elderly patients hospitalized for heart failure.
        Circ Cardiovasc Qual Outcomes. 2014; 7: 251-258
        • Martín-Sánchez F.J.
        • Perdigones J.
        • Ferré Losa C.
        • Llopis F.
        • Navarro Bustos C.
        • Borraz Ordas C.
        • et al.
        180-day risk of mortality in older patients admitted to short-stay units: the 6-month short-stay unit (6 M UCE) score.
        Emergencias. 2018; 30: 315-320
        • Martín-Sánchez F.J.
        • Llopis García G.
        • Llorens P.
        • Jacob J.
        • Herrero P.
        • Gil V.
        • et al.
        Planning to reduce 30-day adverse events after discharge of frail elderly patients with acute heart failure: design and rationale for the DEED FRAIL-AHF trial.
        Emergencias. 2019; 31: 27-35

      Linked Article

      • Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure
        European Journal of Internal MedicineVol. 71
        • Preview
          The Prevalence of Heart Failure (HF) in the western world is around 1-2% and more than 10% over 70 years of age and the incidence is about 5–10 per 1000 persons per year, representing the leading cause of outpatient visits and the most frequent reason of hospitalization for patients over 65 years of age [1]. Comorbidities are a major issue in HF, leading to poor outcomes, excessive hospitalization and mortality. Comorbidities may be subdivided into cardiovascular (CV) and non-CV. HF in elderly patients is associated with more widespread symptoms and signs due to the presence of non-CV comorbidities.
        • Full-Text
        • PDF
      • Comprehensive heart failure assessment: A challenge to modify the course of heart failure. Author's reply
        European Journal of Internal MedicineVol. 74
        • Preview
          We read with great interest the article by JF Martín-Sánchez [1] commenting on our article "Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure" [2]. In his editorial, FJ Martín-Sánchez highlights the need to consider two others specific issues related to comorbidity in heart failure (HF), such as polypharmacy and frailty, to improve outcomes in HF patients with comorbidity. We strongly agree on what is reported about these two issues.
        • Full-Text
        • PDF